359 related articles for article (PubMed ID: 27885836)
1. Texture analysis of medical images for radiotherapy applications.
Scalco E; Rizzo G
Br J Radiol; 2017 Feb; 90(1070):20160642. PubMed ID: 27885836
[TBL] [Abstract][Full Text] [Related]
2. Quantifying tumour heterogeneity in 18F-FDG PET/CT imaging by texture analysis.
Chicklore S; Goh V; Siddique M; Roy A; Marsden PK; Cook GJ
Eur J Nucl Med Mol Imaging; 2013 Jan; 40(1):133-40. PubMed ID: 23064544
[TBL] [Abstract][Full Text] [Related]
3. The role of texture analysis in imaging as an outcome predictor and potential tool in radiotherapy treatment planning.
Alobaidli S; McQuaid S; South C; Prakash V; Evans P; Nisbet A
Br J Radiol; 2014 Oct; 87(1042):20140369. PubMed ID: 25051978
[TBL] [Abstract][Full Text] [Related]
4. Radiotherapy dose painting by circadian rhythm based radiomics.
Abdollahi H
Med Hypotheses; 2019 Dec; 133():109415. PubMed ID: 31586813
[TBL] [Abstract][Full Text] [Related]
5. Radiomics in Nuclear Medicine Applied to Radiation Therapy: Methods, Pitfalls, and Challenges.
Reuzé S; Schernberg A; Orlhac F; Sun R; Chargari C; Dercle L; Deutsch E; Buvat I; Robert C
Int J Radiat Oncol Biol Phys; 2018 Nov; 102(4):1117-1142. PubMed ID: 30064704
[TBL] [Abstract][Full Text] [Related]
6. Identification of robust and reproducible CT-texture metrics using a customized 3D-printed texture phantom.
Varghese BA; Hwang D; Cen SY; Lei X; Levy J; Desai B; Goodenough DJ; Duddalwar VA
J Appl Clin Med Phys; 2021 Feb; 22(2):98-107. PubMed ID: 33434374
[TBL] [Abstract][Full Text] [Related]
7. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
8. Enhancement of multimodality texture-based prediction models via optimization of PET and MR image acquisition protocols: a proof of concept.
Vallières M; Laberge S; Diamant A; El Naqa I
Phys Med Biol; 2017 Oct; 62(22):8536-8565. PubMed ID: 28872054
[TBL] [Abstract][Full Text] [Related]
9. Quantifying tumour heterogeneity with CT.
Ganeshan B; Miles KA
Cancer Imaging; 2013 Mar; 13(1):140-9. PubMed ID: 23545171
[TBL] [Abstract][Full Text] [Related]
10. Delta-radiomics increases multicentre reproducibility: a phantom study.
Nardone V; Reginelli A; Guida C; Belfiore MP; Biondi M; Mormile M; Banci Buonamici F; Di Giorgio E; Spadafora M; Tini P; Grassi R; Pirtoli L; Correale P; Cappabianca S; Grassi R
Med Oncol; 2020 Mar; 37(5):38. PubMed ID: 32236847
[TBL] [Abstract][Full Text] [Related]
11. "Radio-oncomics" : The potential of radiomics in radiation oncology.
Peeken JC; Nüsslin F; Combs SE
Strahlenther Onkol; 2017 Oct; 193(10):767-779. PubMed ID: 28687979
[TBL] [Abstract][Full Text] [Related]
12. Interchangeability of radiomic features between [18F]-FDG PET/CT and [18F]-FDG PET/MR.
Vuong D; Tanadini-Lang S; Huellner MW; Veit-Haibach P; Unkelbach J; Andratschke N; Kraft J; Guckenberger M; Bogowicz M
Med Phys; 2019 Apr; 46(4):1677-1685. PubMed ID: 30714158
[TBL] [Abstract][Full Text] [Related]
13. Multiparametric quantitative and texture
Novikov M
Eur Radiol Exp; 2019 Dec; 3(1):48. PubMed ID: 31853682
[TBL] [Abstract][Full Text] [Related]
14. Texture analysis of T1-w and T2-w MR images allows a quantitative evaluation of radiation-induced changes of internal obturator muscles after radiotherapy for prostate cancer.
Scalco E; Rancati T; Pirovano I; Mastropietro A; Palorini F; Cicchetti A; Messina A; Avuzzi B; Valdagni R; Rizzo G
Med Phys; 2018 Apr; 45(4):1518-1528. PubMed ID: 29415344
[TBL] [Abstract][Full Text] [Related]
15. PET and MRI based RT treatment planning: Handling uncertainties.
Reynaert N
Cancer Radiother; 2019 Oct; 23(6-7):753-760. PubMed ID: 31427076
[TBL] [Abstract][Full Text] [Related]
16. CT radiomics and PET radiomics: ready for clinical implementation?
Bogowicz M; Vuong D; Huellner MW; Pavic M; Andratschke N; Gabrys HS; Guckenberger M; Tanadini-Lang S
Q J Nucl Med Mol Imaging; 2019 Dec; 63(4):355-370. PubMed ID: 31527578
[TBL] [Abstract][Full Text] [Related]
17. Radiomics for Response and Outcome Assessment for Non-Small Cell Lung Cancer.
Shi L; He Y; Yuan Z; Benedict S; Valicenti R; Qiu J; Rong Y
Technol Cancer Res Treat; 2018 Jan; 17():1533033818782788. PubMed ID: 29940810
[TBL] [Abstract][Full Text] [Related]
18. Intrinsic dependencies of CT radiomic features on voxel size and number of gray levels.
Shafiq-Ul-Hassan M; Zhang GG; Latifi K; Ullah G; Hunt DC; Balagurunathan Y; Abdalah MA; Schabath MB; Goldgof DG; Mackin D; Court LE; Gillies RJ; Moros EG
Med Phys; 2017 Mar; 44(3):1050-1062. PubMed ID: 28112418
[TBL] [Abstract][Full Text] [Related]
19. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
20. Studying local tumour heterogeneity on MRI and FDG-PET/CT to predict response to neoadjuvant chemoradiotherapy in rectal cancer.
Schurink NW; van Kranen SR; Berbee M; van Elmpt W; Bakers FCH; Roberti S; van Griethuysen JJM; Min LA; Lahaye MJ; Maas M; Beets GL; Beets-Tan RGH; Lambregts DMJ
Eur Radiol; 2021 Sep; 31(9):7031-7038. PubMed ID: 33569624
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
